LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,342,766 | -11.3% | 781,073 | +17.1% | 0.00% | – |
| Q2 2023 | $4,897,241 | +206.5% | 667,199 | +67.4% | 0.00% | – |
| Q1 2023 | $1,597,901 | +59.9% | 398,479 | +30.0% | 0.00% | – |
| Q4 2022 | $999,461 | -11.2% | 306,583 | +1.3% | 0.00% | – |
| Q3 2022 | $1,126,000 | +20.0% | 302,748 | -0.3% | 0.00% | – |
| Q2 2022 | $938,000 | -42.2% | 303,749 | 0.0% | 0.00% | – |
| Q1 2022 | $1,622,000 | +9.4% | 303,749 | 0.0% | 0.00% | – |
| Q4 2021 | $1,482,000 | -3.4% | 303,749 | +75.2% | 0.00% | – |
| Q3 2021 | $1,534,000 | +1.6% | 173,349 | +4.7% | 0.00% | – |
| Q2 2021 | $1,510,000 | +67.8% | 165,545 | +201.0% | 0.00% | – |
| Q1 2021 | $900,000 | – | 55,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,353,141 | $13,083,464 | 0.76% |
| Integral Health Asset Management, LLC | 760,000 | $4,225,600 | 0.58% |
| Prosight Management, LP | 321,154 | $1,785,616 | 0.57% |
| Parkman Healthcare Partners LLC | 355,957 | $1,979,121 | 0.36% |
| Ikarian Capital, LLC | 514,101 | $2,858,401 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,560,500 | $8,676,380 | 0.04% |
| Polar Capital Holdings Plc | 1,000,000 | $5,560,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 262,265 | $1,458,193 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,614 | $626,134 | 0.02% |
| Point72 Asset Management, L.P. | 825,000 | $4,587,000 | 0.01% |